Is Src the key to understanding metastasis and developing new treatments for colon cancer?

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 5, Issue 6, 2008, Pages 306-307

  Chen, Jiezhong ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANTINEOPLASTIC AGENT; BETA ACTIN; BETA CATENIN; BOSUTINIB; DASATINIB; EVEROLIMUS; FOCAL ADHESION KINASE; KXO 1; LY 294022; MYOSIN LIGHT CHAIN KINASE; N (5 CHLORO 1,3 BENZODIOXOL 4 YL) 7 [2 (4 METHYL 1 PIPERAZINYL)ETHOXY] 5 (TETRAHYDRO 2H PYRAN 4 YLOXY) 4 QUINAZOLINAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE; PROTEIN KINASE C; PROTEIN KINASE SRC; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RAS PROTEIN; RECEPTOR FOR ACTIVATED C KINASE 1; RNA BINDING PROTEIN; SMALL INTERFERING RNA; VASCULOTROPIN; WORTMANNIN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL INTERACTION; CELL MOTILITY; CLINICAL TRIAL; COLON CANCER; DIARRHEA; DOWNSTREAM PROCESSING; DRUG TARGETING; EDEMA; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HUMAN; METASTASIS; MUTATIONAL ANALYSIS; NEUTROPENIA; NONHUMAN; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; GENES, SRC; HUMANS; NEOPLASM METASTASIS;

EID: 44949181869     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1141     Document Type: Article

References (12)

1. National Cancer Institute [http://www.seer.cancer.gov/statfacts/html/ colorect.html]
2. Kopetz S et al. (2007) SRC continues aging: Current and future clinical directions. Clin Cancer Res 13: 7232-7236
3. Nam JS et al. (2002) Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis. Clin Cancer Res 8:2430-2436
4. Thamilselvan V et al. (2004) Colon cancer cell adhesion in response to Src kinase activation and actin-cytoskeleton by non-laminar shear stress. J Cell Biochem 92: 361-371
5. Irby RB et al. (1999) Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet 21: 187-190.
6. Zhu S et al. (2007) PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation. Cancer Res 67: 10129-10137
7. Thamilselvan V et al. (2007) FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-depandent P13K/Akt pathway. FASEB J 21: 1730-1741
8. Avizienyte E et al. (2007) An active Src kinase-beta-actin association is linked to actin dynamics at the periphery of colon cancer cells. Exp Cell Res 313: 3175-3188
9. Etienne-Manneville S and Hall A (2002) Rho GTPases in cell biology. Nature 420: 629-635
10. Avizienyte E and Frame MC (2005) Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol 17: 542-547
11. Busa R et al. (2007) The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells. Oncogene 26: 4372-4382
12. Mamidipudi V et al. (2004) RACK1 regulates G1/S progression by suppressing Src kinase activity. Mol Cell Biol 24: 6788-6798